John Forsayeth

8.4k citations

118 papers · 6.6k indexed · h-index 51

Molecular Biology top 2%
Cellular and Molecular Neuroscience top 0.5%
Genetics top 1%
Neurology top 1%
Physiology top 5%

Co-authors: Krystof S. Bankiewicz Adrian P. Kells John R. Bringas Piotr Hadaczek Lluı́s Samaranch Philip Pivirotto Jamie L. Eberling Waldy San Sebastián
Topics: Virus-based gene therapy research (42 papers)Nerve injury and regeneration (32 papers)RNA Interference and Gene Delivery (21 papers)
Cited by: Cellular and Molecular Neuroscience Developmental Neuroscience Neurology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Medicine
Partner nations: United States Japan Australia

In The Last Decade

John Forsayeth

117 papers receiving 6.5k citations

Peers

Countries citing papers authored by John Forsayeth

Since Specialization

Citations

This map shows the geographic impact of John Forsayeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Forsayeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Forsayeth more than expected).

Fields of papers citing papers by John Forsayeth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Forsayeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Forsayeth. The network helps show where John Forsayeth may publish in the future.

Co-authorship network of co-authors of John Forsayeth

This figure shows the co-authorship network connecting the top 25 collaborators of John Forsayeth. A scholar is included among the top collaborators of John Forsayeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Forsayeth. John Forsayeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GDNF gene therapy for alcohol use disorder in male non-human primates 2023 ·Nature Medicine ·Matthew M. Ford,(unknown),Victor S. Van Laar,Katherine M. Holleran,(unknown),Piotr Hadaczek,(unknown),Emily G. Peck,(unknown),Kousaku Ohno,John R. Bringas,Jodi L. McBride,Lluı́s Samaranch,John Forsayeth,Sara R. Jones,Kathleen A. Grant,Krystof S. Bankiewicz	12
2	Adeno-associated viral vector serotype 9–based gene therapy for Niemann-Pick disease type A 2019 ·Science Translational Medicine ·Lluı́s Samaranch,(unknown),(unknown),Vivek Sudhakar,Jerónimo Jurado‐Arjona,Piotr Hadaczek,Jesús Ávila,John R. Bringas,Josefina Casas,Haifeng Chen,Xingxuan He,Edward H. Schuchman,Seng H. Cheng,John Forsayeth,Krystof S. Bankiewicz,María Dolores Ledesma	34
3	Ganglioside Metabolism and Parkinson's Disease 2018 ·Frontiers in Neuroscience ·John Forsayeth,Piotr Hadaczek	23
4	Axonal transport of AAV9 in nonhuman primate brain 2016 ·Gene Therapy ·(unknown),Lluı́s Samaranch,(unknown),Amy Manning-Bog,Kathrin Meyer,John Forsayeth,Krystof S. Bankiewicz	41
5	Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response 2015 ·Gene Therapy ·Lluı́s Samaranch,Piotr Hadaczek,Adrian P. Kells,John R. Bringas,(unknown),Waldy San Sebastián,(unknown),Sridhar Samineni,Phillip Pivirotto,John Forsayeth,Krys S. Bankiewicz	6
6	Carbidopa-Based Modulation of the Functional Effect of the AAV2-hAADC Gene Therapy in 6-OHDA Lesioned Rats 2015 ·PLoS ONE ·Agnieszka Ciesielska,Nitasha Sharma,Janine Beyer,John Forsayeth,Krystof S. Bankiewicz	13
7	Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate 2014 ·Molecular Therapy — Methods & Clinical Development ·Waldy San Sebastián,Adrian P. Kells,John R. Bringas,Lluı́s Samaranch,Piotr Hadaczek,Agnieszka Ciesielska,(unknown),Phillip Pivirotto,John Forsayeth,(unknown),J. Fraser Wright,(unknown),Gregory Heller,Krystof S. Bankiewicz	27
8	Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model 2013 ·Cancer Gene Therapy ·Dong Yin,You Zhai,Harry E. Gruber,Carlos E. Ibañez,Joan M. Robbins,Adrian P. Kells,Noriyuki Kasahara,John Forsayeth,Douglas J. Jolly,Krys S. Bankiewicz	21
9	Safety Study of Adeno-Associated Virus Serotype 2-Mediated Human Acid Sphingomyelinase Expression in the Nonhuman Primate Brain 2012 ·Human Gene Therapy ·Ernesto A. Salegio,Lluı́s Samaranch,Russell W. Jenkins,Christopher J. Clarke,(unknown),Janine Beyer,Adrian P. Kells,John R. Bringas,Waldy San Sebastián,R. Mark Richardson,(unknown),Yusuf A. Hannun,Krystof S. Bankiewicz,John Forsayeth	19
10	Systemic rapamycin alone may not be a treatment option for malignant glioma: evidence from an in vivo study 2012 ·Journal of Neuro-Oncology ·(unknown),Dali Yin,Piotr Hadaczek,(unknown),John Forsayeth,Krystof S. Bankiewicz	5
11	Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System 2011 ·PLoS ONE ·Piotr Hadaczek,Janine Beyer,Adrian P. Kells,Wade C. Narrow,William J. Bowers,Howard J. Federoff,John Forsayeth,Krystof S. Bankiewicz	15
12	Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain 2010 ·Neuropharmacology ·Piotr Hadaczek,Louisa C. Johnston,John Forsayeth,Krystof S. Bankiewicz	33
13	Chapter 18 Convection-Enhanced Delivery of Liposomes to Primate Brain 2009 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Michal T. Krauze,John Forsayeth,Dali Yin,Krystof S. Bankiewicz	25
14	Controlled dissemination of AAV vectors in the primate brain 2009 ·Progress in brain research ·Vanja Varenika,Adrian P. Kells,Francisco Valles,Piotr Hadaczek,John Forsayeth,Krystof S. Bankiewicz	26
15	Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys 2009 ·Human Gene Therapy ·Louisa C. Johnston,Jamie L. Eberling,Philip Pivirotto,Piotr Hadaczek,Howard J. Federoff,John Forsayeth,Krystof S. Bankiewicz	76
16	Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys 2009 ·Human Gene Therapy ·Jamie L. Eberling,Adrian P. Kells,Philip Pivirotto,Janine Beyer,John R. Bringas,Howard J. Federoff,John Forsayeth,Krystof S. Bankiewicz	80
17	Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates 2009 ·NeuroImage ·Dali Yin,Francisco Valles,Massimo S. Fiandaca,John R. Bringas,Francisco Javier Giménez Fuentes‐Guerra,Mitchel S. Berger,John Forsayeth,Krystof S. Bankiewicz	50
18	Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease 2008 ·Molecular Therapy ·Louisa C. Johnston,Xiaomin Su,Kathleen A. Maguire‐Zeiss,(unknown),Irina Ankoudinova,Dmitry Guschin,Piotr Hadaczek,Howard J. Federoff,Krystof S. Bankiewicz,John Forsayeth	68
19	Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging 2005 ·Brain Research Protocols ·Michal T. Krauze,Tracy R. McKnight,Yoji Yamashita,John R. Bringas,Charles O. Noble,Ryuta Saito,Karsten Geletneky,John Forsayeth,Mitchel S. Berger,Pamela Jackson,John W. Park,Krystof S. Bankiewicz	77
20	UNCL, the mammalian homologue of UNC-50, is an inner nuclear membrane RNA-binding protein11Published on the World Wide Web on 10 August 2000. 2000 ·Brain Research ·Jamie Fitzgerald,Derek Kennedy,Nareerat Viseshakul,Bruce Cohen,John S. Mattick,John F. Bateman,John Forsayeth	31

About John Forsayeth

John Forsayeth is a scholar working on Cellular and Molecular Neuroscience, Developmental Neuroscience and Neurology, having authored 118 papers that have together received 6.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (42 papers), Nerve injury and regeneration (32 papers) and RNA Interference and Gene Delivery (21 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.7k citations), Developmental Neuroscience (350 citations) and Neurology (1.2k citations). John Forsayeth has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Krystof S. Bankiewicz, Adrian P. Kells, John R. Bringas, Piotr Hadaczek, Lluı́s Samaranch, Philip Pivirotto, Jamie L. Eberling, Waldy San Sebastián, Ernesto A. Salegio and Massimo S. Fiandaca. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact